A geographical cluster of progressive supranuclear palsy in northern France. Un cluster géographique de paralysie supranucléaire progressive dans le nord de la France

Archive ouverte

Caparros-Lefebvre, Dominique | Golbe, Lawrence, I | Deramecourt, Vincent | Maurage, Claude-Alain | Huin, Vincent | Buée-Scherrer, Valérie | Obriot, Hélène | Sablonnière, Bernard | Caparros, Francois | Buée, Luc | Lees, Andrew, J.

Edité par CCSD ; American Academy of Neurology -

International audience. Objective: To describe a cluster of progressive supranuclear palsy (PSP) in northern France. PSP has not been reported in geographical, temporal, or occupational clusters. A unit of Neurology and Neurogeriatrics opened in 2005 at the Centre Hospitalier de Wattrelos, serving the population of Wattrelos and Leers (combined population 51,551) and parts of neighboring towns. For most of the 20th century, this area was a center for chromate and phosphate ore processing, textile dyeing, and tanning. Significant industrial waste persists close to residential areas. Methods: From 2005 to 2014, 92 patients with PSP at Centre Hospitalier de Wattrelos were identified and studied. Detailed residential data were available in the medical records. Eighty cases have had magnetic resonance head scanning and 60 have died, of whom 13 have been examined neuropathologically. Results: The ratio of observed to expected PSP incidence over the period 2005 to 2012 was 12.3 (95% confidence interval: 7.4–35.9). Mean onset age was 74.3 years. The Richardson syndrome/PSP-parkinsonism ratio was 43%/42%. Four other phenotypes each occurred in 2% to 5%. Onset was gait/balance difficulty in 52%. None of the 92 affected patients were relatives and 7 were of North African ancestry. MRI was compatible with a clinical diagnostic of PSP in all cases. Histopathologic examination confirmed neurofibrillary degeneration and tufted astrocytes in all autopsied cases. Western blots revealed a typical tau 4R doublet. The tau H1 haplotype occurred in 95.8% of cases' chromosomes. Conclusions: We have identified a cluster of PSP in a geographical area with severe environmental contamination by industrial metals.

Consulter en ligne

Suggestions

Du même auteur

The MAPT gene is differentially methylated in the progressive supranuclear palsy brain. Le gène MAPT est méthylé différentiellement dans le cerveau dans la paralysie supranucléaire progressive. The MAPT gene is differentially methylated in the progressive supranuclear palsy brain: Hypomethylation of MAPT in PSP brain. Le gène MAPT est méthylé différentiellement dans le cerveau dans la paralysie supranucléaire progressive: Hypométhylation de la MAPT dans le cerveau des PSP

Archive ouverte | Huin, Vincent | CCSD

International audience. Background: Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease causing parkinsonian symptoms. Altered DNA methylation of the microtubule-associated protein tau gene corr...

Alternative promoter usage generates novel shorter MAPT mRNA transcripts in Alzheimer’s disease and progressive supranuclear palsy brains. L'utilisation d'un promoteur alternatif de MAPT génère de nouveaux transcrits ARNm plus courts dans le cerveau des malades d'Alzheimer et de paralysie supranucléaire progressive

Archive ouverte | Huin, Vincent | CCSD

International audience. Alternative promoter usage is an important mechanism for transcriptome diversity and the regulation of gene expression. Indeed, this alternative usage may influence tissue/subcellular specifi...

Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation

Archive ouverte | Papegaey, Anthony | CCSD

International audience. AbstractReduction of Tau protein expression was described in 2003 by Zhukareva et al. in a variant of frontotemporal lobar degeneration (FTLD) referred to as diagnosis of dementia lacking dis...

Chargement des enrichissements...